Healthcare Dive

AUGUST 22, 2023

The pharma’s suit, which claims Medicare’s new power to negotiate certain drug prices is unconstitutional, comes days before the agency will reveal the first 10 medicines to be included under the plan.

Medicare 246

Medicare Medicare 246

Healthcare Dive

AUGUST 25, 2022

Prices in the U.S. in July compared to last year, while prices for medical care increased just 4.8%, according to a tracker from the Kaiser Family Foundation and Peterson Center on Healthcare. economy grew 8.5%

335

335

Healthcare Dive

FEBRUARY 6, 2023

No hospitals in HCA Healthcare, Tenet, Providence and UPMC systems were fully compliant with federal price transparency rules, according to a new analysis.

Hospitals 283

Hospitals 283

Healthcare Dive

MARCH 28, 2023

Ohio Attorney General David Yost filed suit on Monday against the payers' PBMs, along with Prime Therapeutics, for allegedly sharing pricing information and driving up drug prices.

274

274

Healthcare Dive

JANUARY 13, 2023

The state filed suit Thursday against pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, alleging they worked with drugmakers to drive up the price of insulin.

274

274

Healthcare Dive

JUNE 6, 2023

The drugmaker’s lawsuit claims the new pricing powers granted by the Inflation Reduction Act are unconstitutional and “tantamount to extortion.”

Medicare 246

Medicare Medicare 246

Healthcare Dive

FEBRUARY 10, 2023

The CMS has laid out how it plans to implement a key provision of the Inflation Reduction Act requiring drugmakers to pay rebates on price hikes in Medicare that are greater than inflation.

Medicare 274

Medicare Medicare 274

Healthcare Dive

MARCH 15, 2022

Turquoise Health's online search platform lists prices for medical procedures and services and offers a scorecard rating the transparency efforts of nearly 6,000 hospitals.

Hospitals 317

Hospitals 317

Healthcare Dive

FEBRUARY 17, 2022

The agency's commissioners will weigh Thursday whether to investigate PBMs and their relationship to drug prices and "practices that may disadvantage independent or specialty pharmacies," according to the meeting agenda.

341

341

Healthcare Dive

AUGUST 10, 2022

Hospitals pushed back on the Patient Rights Advocate report, which found that just 16% of hospitals were fully compliant with the price transparency law.

Hospitals 293

Hospitals 293

Mobi Health News

APRIL 19, 2024

Doug Hirsch, cofounder and chief strategy officer at GoodRx, sat down with MobiHealthNews to talk about reducing prescription drug prices through partnerships.

Prescription Drug Pricing 97

Prescription Drug Pricing 97

Healthcare Dive

MARCH 31, 2023

Former Clinton health policy advisor Kenneth Thorpe argues that federal healthcare price-control policies could wreak havoc in the industry.

279

279

Fierce Healthcare

APRIL 5, 2024

Amwell could find itself dropped from the New York Stock Exchange if it isn’t able to turn its share prices around. | The telehealth giant's shares have closed below $1 on average for the past 30 days. The company said it would address the deficiency by effecting a reverse stock split.

126

126

Healthcare IT Today

MARCH 15, 2024

In this intriguing video, important advances in transparency of health care prices are explained by Mark Galvin, Founder, President and CEO at TALON at the HCAA conference in Las Vegas. Two “watershed moments” have been overlooked by most people, while media coverage focuses on other things such as the No Surprises Act.

Governance 112

Governance Hospitals 112

Fierce Healthcare

DECEMBER 11, 2023

The Lower Costs, More Transparency Act, which advances policies to force pharmacy benefit managers and hospitals to meet price transparency standards, passed on the House floor Monday by a vote of | Members on both sides of the aisle are celebrating successful efforts to codify price transparency requirements and establish site-neutral payments in (..)

Hospitals 138

Hospitals 138

Fierce Healthcare

FEBRUARY 22, 2024

Fans of healthcare price transparency and Grammy Award-winning bands should have their calendars marked for March 5 in Washington, D.C. | The Foo Fighters are joining the fight against price transparency with an upcoming, private concert in Washington, D.C., on behalf of advocacy group Power to the Patients.

123

123

Healthcare Dive

APRIL 19, 2022

Researchers also found that most National Cancer Institute-designated facilities did not publicly disclose payer-specific prices for cancer therapies as required by federal price transparency regulations.

Hospitals 261

Hospitals 261

Healthcare Dive

APRIL 21, 2022

List prices for branded medicines rose by nearly 5% last year, according to Iqvia, a figure that fell to 1% after accounting for rebates and discounts.

246

246

HIT Consultant

DECEMBER 18, 2023

What You Should Know: – PCA Rx and Cost Plus Drugs , are joining forces to tackle the longstanding issue of opaque and inflated drug pricing in the US healthcare system. This partnership combines their expertise to offer an unprecedented level of clarity in drug pricing, addressing a major pain point in the healthcare sector.

111

111

Healthcare Dive

MARCH 22, 2023

Stéphane Bancel said his company's planned price hike covers the higher costs of commercial sales. Bernie Sanders called it part of industry’s “unprecedented level of corporate greed.”

176

176

Healthcare Dive

AUGUST 9, 2023

The study, published in Health Affairs, found large national insurers had higher price ratios than other payers.

Hospitals 245

Hospitals 245

Electronic Health Reporter

APRIL 27, 2021

While there has been a big focus on pharmaceutical companies and their sky-high prices in the media, including previously […]. The article How New Drugs Are Priced appeared first on electronichealthreporter.com. According to Statista, in 2019, U.S. drug store and pharmacy sales totaled nearly 297 billion dollars.

172

172

Fierce Healthcare

JANUARY 23, 2024

Price transparency data startup Turquoise Health clinched $30 million in fresh funding to build out its capabilities. Price transparency data startup Turquoise Health clinched $30 million in fresh funding to build out its capabilities.

Compliance 115

Compliance 115

Fierce Healthcare

JANUARY 3, 2024

A “pivotal year for price transparency” closed out with most—but not all—of the healthcare industry publishing their data publicly and at a higher quality, price transparency data startup Turquoise | A state-of-the-industry report released Thursday found steady improvements in the number of organizations releasing price data, as well as the comprehensiveness (..)

Hospitals 130

Hospitals Compliance 130

Healthcare IT Today

JANUARY 31, 2024

Price Transparency is the Foundation for Eliminating the Financial Complexity of Healthcare Turquoise Health , an end-to-end healthcare pricing platform, today announced a $30M Series B investment led by Adams Street Partners , with participation from Yosemite , as well as existing investors Andreessen Horowitz and BoxGroup.

Compliance 104

Compliance Hospitals 104

Healthcare Dive

MARCH 15, 2023

Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases they take that exceed inflation. But they won’t need to pay until 2025.

Medicare 130

Medicare Medicare 130

Healthcare Dive

JUNE 16, 2022

Millions of Americans will experience dramatic price increases, become uninsured and likely accrue medical debt, GetInsured’s Heather Korbulic argues.

246

246

Fierce Healthcare

DECEMBER 5, 2023

CVS Health is overhauling the way it reimburses its pharmacies for prescription medications as the healthcare industry faces increased scrutiny for high drug prices. | CVS Health is overhauling the way it reimburses its pharmacies for prescription medications as the healthcare industry faces increased scrutiny on high drug prices.

118

118

Fierce Healthcare

DECEMBER 18, 2023

Legal experts indicated they will be paying close attention to lawsuits surrounding the Medicare drug price negotiation program and Braidwood v. Preventative services covered under the Affordable Care Act and the Medicare drug price negotiations program are two legal questions that will play out next year.

Medicare 113

Medicare Medicare 113

Electronic Health Reporter

MARCH 27, 2024

By Derek Reis-Larson, senior vice president, claims pricing services, MultiPlan.

91

91

Fierce Healthcare

JANUARY 5, 2024

In his first earnings call since taking over as CEO of Walgreens, Tim Wentworth signaled the drugstore retail giant is exploring new pharmacy models as cost-plus drug pricing gains momentum. |

115

115